Business Description
Gamida Cell Ltd
ISIN : IL0011552663
Description
Gamida Cell Ltd is a clinical-stage biopharmaceutical company that is pioneering a diverse immunotherapy pipeline of potentially curative cell therapy candidates for patients with solid tumors blood cancers and other serious blood diseases. The company applies a proprietary expansion platform leveraging the properties of nicotinamide, or NAM, to allogeneic cell sources including umbilical cord blood-derived cells and natural killer, or NK, cells to create cell therapy candidates with the potential to redefine standards of care. Its primary product candidate is Omidubicel, an advanced cell therapy candidate for allogeneic hematopoietic stem cell transplant and GDA-201 is the company's lead investigational NK cell-based cancer immunotherapy product candidate.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | -0.24 | |||||
| Debt-to-Equity | -4.17 | |||||
| Debt-to-EBITDA | -1.35 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -11.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29.5 | |||||
| 3-Year EPS without NRI Growth Rate | 20.1 | |||||
| 3-Year FCF Growth Rate | 19.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.48 | |||||
| 9-Day RSI | 42.61 | |||||
| 14-Day RSI | 31.17 | |||||
| 6-1 Month Momentum % | -95.25 | |||||
| 12-1 Month Momentum % | -99.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | |||||
| Quick Ratio | 0.33 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 85.69 | |||||
| Days Sales Outstanding | 150.74 | |||||
| Days Payable | 126.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -34.8 | |||||
| Shareholder Yield % | -1059.67 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -241.92 | |||||
| Operating Margin % | -2924.42 | |||||
| Net Margin % | -2317.95 | |||||
| FCF Margin % | -2998.39 | |||||
| ROA % | -59.93 | |||||
| ROIC % | -113.84 | |||||
| ROC (Joel Greenblatt) % | -131.3 | |||||
| ROCE % | -91.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.89 | |||||
| EV-to-EBIT | -0.92 | |||||
| EV-to-Forward-EBIT | -1.08 | |||||
| EV-to-EBITDA | -0.97 | |||||
| EV-to-Revenue | 20.92 | |||||
| EV-to-Forward-Revenue | 11.24 | |||||
| EV-to-FCF | -0.7 | |||||
| Earnings Yield (Greenblatt) % | -108.7 | |||||
| FCF Yield % | -3062.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GMDAQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gamida Cell Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.674 | ||
| EPS (TTM) ($) | -0.49 | ||
| Beta | 0 | ||
| Volatility % | 122.31 | ||
| 14-Day RSI | 31.17 | ||
| 14-Day ATR ($) | 0.00622 | ||
| 20-Day SMA ($) | 0.015438 | ||
| 12-1 Month Momentum % | -99.25 | ||
| 52-Week Range ($) | 0.008 - 2.51 | ||
| Shares Outstanding (Mil) | 154.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gamida Cell Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gamida Cell Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gamida Cell Ltd Frequently Asked Questions
What is Gamida Cell Ltd(GMDAQ)'s stock price today?
The current price of GMDAQ is $0.02. The 52 week high of GMDAQ is $2.51 and 52 week low is $0.01.
When is next earnings date of Gamida Cell Ltd(GMDAQ)?
The next earnings date of Gamida Cell Ltd(GMDAQ) is 2025-03-27 Est..
Does Gamida Cell Ltd(GMDAQ) pay dividends? If so, how much?
Gamida Cell Ltd(GMDAQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers